ReviewThe EPMA journal2023
Emerging frontiers of artificial intelligence and machine learning in ischemic stroke: a comprehensive investigation of state-of-the-art methodologies, clinical applications, and unraveling challenges.
Review in The EPMA journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 18 citations in OpenAlex.
- Artificial Intelligence and Emerging Digital Technologies Across the Stroke Continuum: From Risk Prediction to Real-Time Monitoring and Rapid Response.Medicina (Kaunas, Lithuania) · 2026Review
- Insights into the interplay between stroke and depression through lipid metabolism-related diagnostic genes.Molecular brain · 2026Article
- Harnessing extracellular vesicles for ischemic stroke management.Regenerative biomaterials · 2026Review
- Cerebrospinal fluid-based clinical-radiomics model for predicting treatment prognosis of acute ischemic stroke.Quantitative imaging in medicine and surgery · 2025Article
- Review
- Clinical trials and advanced MRI techniques with stem cell therapy for ischemic stroke: present and future perspectives.Journal of translational medicine · 2025Review
- Low-Molecular-WeightFood science & nutrition · 2025Article
- Review
- Review
- Prediction of the functional outcome of intensive inpatient rehabilitation after stroke using machine learning methods.Scientific reports · 2025Article
- Pyridoxal 5'-phosphate and risk of stroke: triangulation of evidence from a nationally representative cohort and bidirectional Mendelian randomization analysis.The EPMA journal · 2025Article
- Article
- Deep-learning-based detection of large vessel occlusion: A comparison of CT and diffusion-weighted imaging.Digital healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
At present, stroke remains the second highest cause of death globally and a leading cause of disability. From 1990 to 2019, the absolute number of strokes worldwide increased by 70.0%, and the prevalence of stroke increased by 85.0%, causing millions of deaths and disability. Ischemic stroke accounts for the majority of strokes, which is caused by arterial occlusion. Effective primary prevention strategies, early diagnosis, and timely interventions such as rapid reperfusion are in urgent implementation to control ischemic stroke. Otherwise, the stroke burden will probably continue to grow across the world as a result of population aging and an ongoing high prevalence of risk factors. To help with the diagnosis and management of ischemic stroke, newer techniques such as artificial intelligence (AI) are highly anticipated and may bring a new revolution. AI is a recent fast-growing research area which aims to mimic cognitive processes through a number of techniques such as machine learning (ML) methods of random forest learning (RFL) and convolutional neural networks (CNNs). With the help of AI, several momentous milestones have already been attained across diverse dimensions of ischemic stroke. In the context of predictive, preventive, and personalized medicine (PPPM/3PM), we aim to transform stroke care from a reactive to a proactive and individualized paradigm. In this way, AI demonstrates strong clinical utility across all three levels of prevention in ischemic stroke. In this paper, we synoptically illustrated the history and current situation of AI and ML. Then, we summarized their clinical applications and efficacy in the management of stroke. We finally provided an outlook on how AI approaches might contribute to enhancing favorable outcomes after stroke and proposed our suggestions on developing AI-based PPPM strategies. Supplementary Information: The online version contains supplementary material available at 10.1007/s13167-023-00343-3.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.